Horizon Therapeutics Public Limited Company (HZNP) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

T E P E Z Z AK R Y S T E X X AR A V I C T IP R O C Y S B IActimmuneP E N N S A I D Two PercentR A Y O SU P L I Z N AB U P H E N Y LD U E X I S ProductVimovoQ U I N S A I ROrphan Segment Net SalesInflammation
0375M750M1B2B2B2B3B3BQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue by Geography

UNITED STATESNon-USNon Us
0250M500M750M1B1B2B2B2BQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0375M750M1B2B2B2B3B3BQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
075M150M225M300M375M450M525M600MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EBITDA

EBITDA
050M100M150M200M250M300M350M400MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EPS

EPSEPS Diluted
000111222Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue Variation (%)

Revenue Variation
-20-15-10-505101520Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
075150225300375450525600Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-20-16-13-9-6-2259Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Price-to-Earning Ratio

P/E Ratio
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
01020304050607080Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
050M100M150M200M250M300M350M400MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
012345678Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0125M250M375M500M625M750M875M1BQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Cash Flow to Debt Ratio

Cash At End Of Period
0375M750M1B2B2B2B3B3BQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023
🏦 Balance Sheet
📈 Key Metrics